29th Annual TNP Conference Workshop F21 Evaluation - Genetic Variation in Candidate Biomarkers Predicts Recover & May Affect Biomarker Utility Survey

	Strongly Disagree	Disagree	Agree	Strongly Agree
Describe the state-of-the science for traumatic brain injury as it relates to understanding pathology and guiding treatment (RX)	Describe the state-of-the science for traumatic brain injury as it relates to understanding pathology and guiding treatment (RX) Strongly Disagree	Describe the state-of-the science for traumatic brain injury as it relates to understanding pathology and guiding treatment (RX) Disagree	Describe the state-of-the science for traumatic brain injury as it relates to understanding pathology and guiding treatment (RX) Agree	Describe the state-of-the science for traumatic brain injury as it relates to understanding pathology and guiding treatment (RX) Strongly Agree
List 3 of the most promising biomarkers for brain injury to date, and how they may guide therapy selection (RX)	List 3 of the most promising biomarkers for brain injury to date, and how they may guide therapy selection (RX) Strongly Disagree	List 3 of the most promising biomarkers for brain injury to date, and how they may guide therapy selection (RX) Disagree	List 3 of the most promising biomarkers for brain injury to date, and how they may guide therapy selection (RX) Agree	List 3 of the most promising biomarkers for brain injury to date, and how they may guide therapy selection (RX) Strongly Agree
Gain knowledge surrounding what single nucleotide polymorphis (SNPs) are how they are assessed	Gain knowledge surrounding what single nucleotide polymorphis (SNPs) are how they are assessed Strongly Disagree	Gain knowledge surrounding what single nucleotide polymorphis (SNPs) are how they are assessed Disagree	Gain knowledge surrounding what single nucleotide polymorphis (SNPs) are how they are assessed Agree	Gain knowledge surrounding what single nucleotide polymorphis (SNPs) are how they are assessed Strongly Agree
Describe how SNPs could affect recovery and alter circulating biomarker levels	Describe how SNPs could affect recovery and alter circulating biomarker levels Strongly Disagree	Describe how SNPs could affect recovery and alter circulating biomarker levels Disagree	Describe how SNPs could affect recovery and alter circulating biomarker levels Agree	Describe how SNPs could affect recovery and alter circulating biomarker levels Strongly Agree
Discuss how genomic and protein data is relevant to the quest for personalized medicines as part of the precision medicine initiative	Discuss how genomic and protein data is relevant to the quest for personalized medicines as part of the precision medicine initiative Strongly Disagree	Discuss how genomic and protein data is relevant to the quest for personalized medicines as part of the precision medicine initiative Disagree	Discuss how genomic and protein data is relevant to the quest for personalized medicines as part of the precision medicine initiative Agree	Discuss how genomic and protein data is relevant to the quest for personalized medicines as part of the precision medicine initiative Strongly Agree

Strongly Disagree

Disagree

Agree

Strongly Agree

Describe the state-of-the science for traumatic brain injury as it relates to understanding pathology and guiding treatment (RX)

Describe the state-of-the science for traumatic brain injury as it relates to understanding pathology and guiding treatment (RX) Strongly Disagree

Describe the state-of-the science for traumatic brain injury as it relates to understanding pathology and guiding treatment (RX) Disagree

Describe the state-of-the science for traumatic brain injury as it relates to understanding pathology and guiding treatment (RX) Agree

Describe the state-of-the science for traumatic brain injury as it relates to understanding pathology and guiding treatment (RX) Strongly Agree

List 3 of the most promising biomarkers for brain injury to date, and how they may guide therapy selection (RX)

List 3 of the most promising biomarkers for brain injury to date, and how they may guide therapy selection (RX) Strongly Disagree

List 3 of the most promising biomarkers for brain injury to date, and how they may guide therapy selection (RX) Disagree

List 3 of the most promising biomarkers for brain injury to date, and how they may guide therapy selection (RX) Agree

List 3 of the most promising biomarkers for brain injury to date, and how they may guide therapy selection (RX) Strongly Agree

Gain knowledge surrounding what single nucleotide polymorphis (SNPs) are how they are assessed

Gain knowledge surrounding what single nucleotide polymorphis (SNPs) are how they are assessed Strongly Disagree

Gain knowledge surrounding what single nucleotide polymorphis (SNPs) are how they are assessed Disagree

Gain knowledge surrounding what single nucleotide polymorphis (SNPs) are how they are assessed Agree

Gain knowledge surrounding what single nucleotide polymorphis (SNPs) are how they are assessed Strongly Agree

Describe how SNPs could affect recovery and alter circulating biomarker levels

Describe how SNPs could affect recovery and alter circulating biomarker levels Strongly Disagree

Describe how SNPs could affect recovery and alter circulating biomarker levels Disagree

Describe how SNPs could affect recovery and alter circulating biomarker levels Agree

Describe how SNPs could affect recovery and alter circulating biomarker levels Strongly Agree

Discuss how genomic and protein data is relevant to the quest for personalized medicines as part of the precision medicine initiative

Speaker(s) fully disclosed any conflict of interest and discussion of off-label usage of medication and/or medical devices at beginning of, or during the presentation.

Strongly Disagree

Disagree

Agree

Strongly Agree

Strongly Disagree

Disagree

Agree

Strongly Agree

Question Title

I would recommend this speaker for future conference.

Strongly Disagree

Disagree

No Opinion

Agree

Strongly Agree

Strongly Disagree

Disagree

No Opinion

Agree

Strongly Agree

Question Title

F21: As a result of my participation in the Genetic Variation in Candidate Biomarkers Predicts Recover & May Affect Biomarker Utility, I am better to:

Question Title

The teaching methods used were appropriate to the objectives.

Question Title

Nicole Osier demonstrated experimental knowledge of the topic.

Question Title

The individual objectives/content topic were cohesive with one another.

Question Title

The content of the program was balanced and free of commercial bias.

Question Title

Speaker(s) fully disclosed any conflict of interest and discussion of off-label usage of medication and/or medical devices at beginning of, or during the presentation.

Question Title

I would recommend this speaker for future conference.